Results 1 to 10 of about 78,685 (264)

Gene transfer and genome editing of T cells for cancer immunotherapy: from allogeneic HSCT to TCR gene editing. [PDF]

Hematology Am Soc Hematol Educ Program
Bonini C.
europepmc   +1 more source

Locoregional delivery of CAR T cells in high-grade gliomas: a systematic analysis of safety, efficacy, and emerging biomarkers of response. [PDF]

J Immunother Cancer
Ramsoomair CK, Daftari M, Benchouia R, Estevez-Ordonez D, Aka A, Himic V, Aramburu-Berckemeyer M, Kreatsoulas D, Govindarajan V, Chandar JS, Ivan ME, Komotar RJ, Shah A.   +12 more
europepmc   +1 more source

IL-12-secreting CAR-T cells reprogram the tumor microenvironment and improve efficacy against heterogeneous models of glioblastoma. [PDF]

J Immunother Cancer
Shen S, Mohan AA, Hotchkiss KM, Cook S, Patel K, Moelker E, Puviindran B, Gonzalez AT, Zaidi S, Spellicy S, Schwartz A, Suryadevara C, Wilkinson D, Ayasoufi K, Fecci PE, Sanchez-Perez L, Sampson J, Patel A.   +17 more
europepmc   +1 more source

Donor-derived CD19-targeted CAR-NK cells induce complete remission in a child with relapsed B-ALL after failure of blinatumomab and autologous CD19-targeted CAR-T. [PDF]

J Immunother Cancer
Wang N, Liu L, Zhang L, Li J, Wan Y, Li X, Chen X, Yin Z, Zhang A, Zhang X, Chen Y, Hu T, Zhang Y, Liu F, Zhu X, Yang W.   +15 more
europepmc   +1 more source

Chimeric antigen receptor T cell therapy: Revolutionizing cancer treatment. [PDF]

World J Clin Oncol
Arjumand S, Raj A, Prattay KMR, Omer HBM, Azam F.   +4 more
europepmc   +1 more source

CAR-T therapy moving to first-line in multiple myeloma: latest updates from the 2025 ASH annual meeting. [PDF]

J Hematol Oncol
Geng C, Chen W, Zhu HH.
europepmc   +1 more source

Neurological implications of chimeric antigen receptor-T cell therapy. [PDF]

BMJ Neurol Open
Raffoul DG, Roos I, Mulazzani M, Anderson MA, Monif M, Garber J, van der Walt A, Massey J, Kuznetsova V, Nesbitt C, Dowling M, Ruderman I, Lasocki A, Tam CS, Harrison SJ, Kalincik T.   +15 more
europepmc   +1 more source

Endogenous immune recruitment in glioblastoma CAR T therapy: cytokine, myeloid, and chemokine circuitry. [PDF]

J Neurooncol
Liu J, Abikenari M, Annagiri S, Ha JH, Nageeb G, Sjoholm MA, Velazhahan V, Medikonda R, Choi J, Li G, Lim M.   +10 more
europepmc   +1 more source

Next-generation immune cell therapies for lung cancer: advances in CAR-T, NK, and TIL strategies. [PDF]

Front Med (Lausanne)
Khan A, Mujahid A, Tareen A, Amin A, Khan SR, Hadi DK, Raza A.   +6 more
europepmc   +1 more source

Progress in the Treatment of Refractory Myasthenia Gravis. [PDF]

Rev Neurol
Liu D, Mao J, Song J, Wang M.
europepmc   +1 more source